OrthoTrophix
CA - Foster CityBiotechnology
Focus: OrthoTrophix is a private biotech company focused on bone, cartilage, and teeth therapies within the musculoskeletal disease space. The company is early-stage with a focused pipeline targeting osteoarthritis.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Funding Stage
PRIVATE
Open Jobs
0
About OrthoTrophix
AI assessmentNot HiringNo open roles listed right now. Follow OrthoTrophix to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Previous treated with TPX-100
Mild to Moderate Knee OAClinical Trials (1)
NCT03125499A Prospective Observational Study to Evaluate Long-term Changes in Cartilage Morphology in Subjects Who Previously Received TPX-100 or Placebo in Study TPX-100-1 for Patellar Osteoarthritis Involving Both Knees
N/AHelp build intelligence for OrthoTrophix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.